Tag: CMP
US FDA approves Compumedics’ MEG neuroimaging technology enabling insurers to be billed
Compumedics (ASX: CMP) has collared US Food and Drug Administration approval for its neuroimaging technology, enabling insurers to be billed for the scan.
On Friday, the FDA officially granted 510(...
Compumedics boosts after tax profit by 133%
Compumedics (ASX: CMP) has delivered a net after tax profit of $2.8 million for the full year ending June 2018 – an increase of 133% on the previous year’s $1.3 million.
Meanwhile, earnings before ...
Compumedics’ new distribution agreement strengthens ongoing growth in Asia’s neuro-diagnostic and monitoring market
Australia-based medical device company Compumedics (ASX: CMP) has continued its ongoing development and focus in Asia with a new three-year distribution agreement with one of Japan’s leading medical d...
Compumedics plans to ‘make history’ with Somfit health joint venture in China
Compumedics (ASX: CMP) has entered into an agreement with leading China-based health-check organisation Meinian Onehealth Healthcare Holdings (Health 100) to work together over the next 90 days to fin...
Compumedics signs major distribution agreements in China worth at least A$15m
Compumedics (ASX: CMP) has negotiated a new distribution agreements with three of the company’s long-standing distributors in China, for its sleep, neuro-diagnostic and monitoring systems.
The agreem...
Compumedics confirms sustainable profitability with contract win and continued eHealth growth forecast
One of Australia’s leading medical device companies, Compumedics (ASX: CMP), announced this week, record sales orders of A$18.5 million for first half year having secured its largest system contract i...
